A study in chronic myeloid leukemia showed that the administration of proteasome inhibitor oprozomib could induce cell apoptosis via ASK-JNK-Bim axis (Wang et al., 2021). The gene discussed is MAPK8; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.